Literature DB >> 7241025

Multiple sclerosis in the Orkney and Shetland Islands. V: The effect on viral titres of histocompatibility determinants.

D C Poskanzer, J L Sever, P I Terasaki, L B Prenney, J L Sheridan, M S Park.   

Abstract

HLA phenotypes were correlated with serum antibody titres to eight viruses in patients with multiple sclerosis and two matched control groups in the Orkney Islands. In patients, no specific HLA antigen was associated wtih increased or decreased viral titres. However, HLA-B7 was significantly correlated with higher measles titres in healthy controls. Furthermore, controls who had the HLA haplotypes, B7, DW2 ad B-cell 4, demonstrated significantly higher antibody titres to measles and rubella than controls without these determinants (P less than 0.005). To determine the effect of age, sex, and other variables upon viral titres, regression analysis was undertaken. A significant proportion of measles titre variance in patients was explained by sex and clinical factors. Among normal controls, HLA determinants explained a significant amount of measles and rubella titre variance. These data suggest that viral titres in normal individuals are influenced by certain HLA antigens and give indirect evidence that another, as yet undefined, determinant in the histocompatibility complex governs the immune response.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7241025      PMCID: PMC1052089          DOI: 10.1136/jech.34.4.265

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN: 0143-005X            Impact factor:   3.710


  23 in total

1.  Measles antibodies as related to HL-A types in multiple sclerosis.

Authors:  D W Paty; J Furesz; D W Boucher; C G Rand; C R Stiller
Journal:  Neurology       Date:  1976-07       Impact factor: 9.910

2.  Linkage between immune response potential to DNA and X chromosome.

Authors:  E Mozes; S Fuchs
Journal:  Nature       Date:  1974-05-10       Impact factor: 49.962

3.  Virus antibody titers in multiple sclerosis patients, siblings, and controls.

Authors:  J A Brody; J L Sever; T E Henson
Journal:  JAMA       Date:  1971-05-31       Impact factor: 56.272

4.  Virus antibodies and multiple sclerosis.

Authors:  J L Sever; J F Kurtzke; M Alter; G A Schumacher; M R Gilkeson; J H Ellenberg; J A Brody
Journal:  Arch Neurol       Date:  1971-06

5.  HL-A, immune-response genes, and disease.

Authors:  H O McDevitt; W F Bodmer
Journal:  Lancet       Date:  1974-06-22       Impact factor: 79.321

6.  Letter: HL-A antigens in myasthenia gravis.

Authors:  D Fritze; C Herrmann; F Naeim; G S Smith; R L Walford
Journal:  Lancet       Date:  1974-07-06       Impact factor: 79.321

7.  Lack of association between HL-A antigens and measles antibody in multiple sclerosis.

Authors:  J Bertrams; E von Fisenne; P G Hoher; E Kuwert
Journal:  Lancet       Date:  1973-08-25       Impact factor: 79.321

8.  Histocompatibility types and measles antibodies in multiple sclerosis and optic neuritis.

Authors:  B G Arnason; T C Fuller; J R Lehrich; S H Wray
Journal:  J Neurol Sci       Date:  1974-08       Impact factor: 3.181

9.  HL-A antigens and diseases. I. Multiple sclerosis.

Authors:  C Jersild; A Svejgaard; T Fog; T Ammitzboll
Journal:  Tissue Antigens       Date:  1973

10.  Histocompatibility-linked genetic control of disease susceptibility. Murine lymphocytic choriomeningitis virus infection.

Authors:  M B Oldstone; F J Dixon; G F Mitchell; H O McDevitt
Journal:  J Exp Med       Date:  1973-05-01       Impact factor: 14.307

View more
  5 in total

1.  Anti HTLV-I antibodies and HLA phenotypes in the West Indies.

Authors:  M Chavance; N Monplaisir; I Valette; L Schaffar-Deshayes; C Raffoux
Journal:  Clin Exp Immunol       Date:  1989-07       Impact factor: 4.330

2.  Multiple sclerosis in the Orkney and Shetland Islands and in north-east Scotland.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1981-02-14

3.  Genome-wide homozygosity and multiple sclerosis in Orkney and Shetland Islanders.

Authors:  Rebekah E McWhirter; Ruth McQuillan; Elizabeth Visser; Carl Counsell; James F Wilson
Journal:  Eur J Hum Genet       Date:  2011-09-07       Impact factor: 4.246

4.  Multiple sclerosis in the Orkney and Shetland Islands. II: The search for an exogenous aetiology.

Authors:  D C Poskanzer; J L Sheridan; L B Prenney; A M Walker
Journal:  J Epidemiol Community Health       Date:  1980-12       Impact factor: 3.710

5.  Viral antibody titers, immunogenetic markers, and their interrelations in multiple sclerosis patients and controls.

Authors:  A Alpérovitch; C Berr; A Cambon-Thomsen; J Puel; J M Dugoujon; J B Ruidavets; M Clanet
Journal:  Hum Immunol       Date:  1991-06       Impact factor: 2.850

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.